Vanguard U.S. Multifactor FundVFMFX
Type
Mutual fund
Peer group
US equity: mid companies
Net assets
$248.3M
Expense ratio
0.18%
1-year return
+21.2%
3 years, a year
+18.2%
5 years, a year
+14.0%
Holdings
602
What it aims to do.
Vanguard U.S. Multifactor Fund (the Fund) seeks to provide long-term capital appreciation by investing in stocks with relatively strong recent performance, strong fundamentals, and low prices relative to fundamentals as determined by the advisor.
Top 10 holdings.
| Holding | % of fund |
|---|---|
| NEM Newmont Corp | 1.09% |
| MU Micron Technology Inc | 0.94% |
| GILD Gilead Sciences Inc | 0.91% |
| HCA HCA Healthcare Inc | 0.91% |
| BNY Bank of New York Mellon Corp/The | 0.90% |
| BMY Bristol-Myers Squibb Co | 0.87% |
| REGN Regeneron Pharmaceuticals Inc | 0.85% |
| ABBV AbbVie Inc | 0.85% |
| MCK McKesson Corp | 0.84% |
| MO Altria Group Inc | 0.82% |
More on VFMFX.
- VFMFX overview
- VFMFX holdings
- VFMFX risk
- VFMFX costs
- VFMFX money in and out
- VFMFX share classes
- Compare VFMFX with other funds
Returns after fees, from the fund's SEC filings up to Feb 2026. Past returns are not a promise. Not financial advice.